loader2
Partner With Us NRI

Company details

57.70
57.70
47.00
92.60
6M Return -8.99%
1Y Return -22.03%
Mkt Cap.(Cr) 9.04
Volume 9
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 9

Open Free Demat Account Online with ICICIDIRECT

SWOT

  • swot

  • technicals

  • deals

  • shareholding


EMA SMA

Delivery and volume

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after tax

PE

Debt/Equity

P BV

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 15.60 Cr FV: 10.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 25,587.81 -37,752.78
LAST 3M 74,012.99 -52,283.98
LAST 6M 141,118.09 -186,787.74
LAST 12M 210,989.03 -181,030.70

Information

  • About Company
  • Company Info
  • Listing Info
131.51
49.17%
99.8367
0.53%
1.23%
Description
  • Relish Pharmaceuticals Ltd is a public limited company with a global perspective, manufacturing, exporting and marketing in both domestic and international markets. The company was incorporated on March 4, 1993 as a private limited company with the name Relish Pharmaceuticals Pvt Ltd. In August 31, 1993, the company was converted into a public limited company and the name was changed to Relish Pharmaceuticals Ltd. The company provides varieties of products to the clientele. Their product portfolio includes Antibiotics (Penicillin), Anti Biotics (Cephalosporin), Anti Biotics, Macrolides, Quinolones, Anti Bacterial, Anti Fungal, Anti Malarial, Anti Viral, Anti Protozoal, Anti Anthelmintic, Sedative and Tranquilliser, Anti Depressant, Anti Manic, Anti Emetic, Anti Ulcer, Beta Blockers, Diuretics, Analgesic, Analgesic (NASID), Muscle Relaxants, Anti Tuberculosis, Vitamin Products, Anti Allergics, Corticosteroids, Hyper and Hypoglycemic, Others. The company has four manufacturing divisions namely tablets (General and Beta Lactum) Capsules (General and Beta Lactum), Liquid and small volume parental. Their manufacturing unit is located at Rakanpur in Gujarat. The company customers include leading Manufacturers like Cadila Healthcare Limited (Zydus), Intas Pharmaceuticals Limited, Cadila Pharmaceuticals Limited, Makers Laboratories Limited, Agenta Pharma Limited etc. The company has assisted in the development and manufacture of a wide variety of drugs and dosage forms and potency variations for many prestigious pharmaceuticals companies around the world.

Read More

Registered Address

3 rd Floor Dev House, Opp WIAA Office Judges Bungalo, Ahmedabad, Gujarat, 380054

Tel : 91-079-66522247/27498515
Email : info:relishpharma.com
Website : http://www.relishpharma.com

Registrar

Sharepro Services

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 524632
NSE Code :
Book Closure Date (Month) : Sep
BSE Group : X
ISIN : INE551C01028

ICICIdirect Shukra Pharmaceuticals Ltd FAQ

You can buy Shukra Pharmaceuticals Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Shukra Pharmaceuticals Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of May 26, 2022 03:40 PM the closing price of Shukra Pharmaceuticals Ltd was ₹ 57.70.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of May 26, 2022 03:40 PM, the market cap of Shukra Pharmaceuticals Ltd stood at ₹ 9.04.
The latest PE ratio of Shukra Pharmaceuticals Ltd as of May 26, 2022 03:40 PM is 131.51
The latest PB ratio of Shukra Pharmaceuticals Ltd as of May 26, 2022 03:40 PM is 1.77
The 52-week high of Shukra Pharmaceuticals Ltd is ₹ 92.60 while the 52-week low is ₹ 47.00 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE